European Oncology Nursing Society breakthrough cancer pain guidelines

European Journal of Oncology Nursing

Volumn 18, Issue 2, 2014, Pages 127-131

  Wengström, Yvonne ^a   Geerling, Jenske ^d   Rustøen, Tone ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c LOVISENBERG DIACONAL UNIVERSITY COLLEGE   (Norway)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Assessment; Breakthrough cancer pain; Evidence based; Guideline; Management

Indexed keywords

ANALGESIA; ARTICLE; ASSESSMENT; BREAKTHROUGH CANCER PAIN; BREAKTHROUGH PAIN; EUROPE; EVIDENCE BASED MEDICINE; EVIDENCE-BASED; FEMALE; GUIDELINE; HUMAN; MALE; MANAGEMENT; NEOPLASM; NURSING; NURSING ORGANIZATION; ONCOLOGY NURSING; PAIN ASSESSMENT; PRACTICE GUIDELINE; SEVERITY OF ILLNESS INDEX; STANDARD; TREATMENT OUTCOME;

ASSESSMENT; BREAKTHROUGH CANCER PAIN; EVIDENCE-BASED; GUIDELINE; MANAGEMENT;

BREAKTHROUGH PAIN; EUROPE; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; NEOPLASMS; ONCOLOGY NURSING; PAIN MANAGEMENT; PAIN MEASUREMENT; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; SOCIETIES, NURSING; TREATMENT OUTCOME;

EID: 84894650121     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2013.11.009     Document Type: Article

References (25)

1. Barosi G. Strategies for dissemination and implementation of guidelines. Neurological Science 2006, 27(Suppl.3):S231-S234.
2. Breivik H., Cherny N., Collett B., de Conno F., Filbet M., Foubert A.J., et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Annals of Oncology 2009, 20(8):1420-1433.
3. Caraceni A., Martini C., Zecca E., Portenoy R.K., Ashby M.A., Hawson G., et al. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliative Medicine 2004, 18(3):177-183.
4. Chang V.T., Hwang S.S., Feuerman M., Kasimis B.S. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 2000, 88(5):1175-1183.
5. Davies A., Zeppetella G., Andersen S., Damkier A., Vejlgaard T., Nauck F., et al. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. European Journal of Pain 2011, 15(7):756-763.
6. Davies A.N. Cancer-related breakthrough pain. British Journal of Hospital Medicine (London) 2006, 67(8):414-416.
7. Davies A.N. The management of breakthrough cancer pain. British Journal of Nursing 2011, 20(13):803-804. 806-807.
8. Davies A.N., Dickman A., Reid C., Stevens A.M., Zeppetella G. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. European Journal of Pain 2009, 13(4):331-338.
9. Fine P.G., Busch M.A. Characterization of breakthrough pain by hospice patients and their caregivers. Journal of Pain and Symptom Management 1998, 16(3):179-183.
10. Gilbertson-White S., Aouizerat B.C., Jahan T., Miaskowski C. Areview of the literature on multiple symptoms, their predictors, and associated outcomes in patients with advanced cancer. Palliative and Supportive Care 2011, 9(1):81-102.
11. Greco M.T., Corli O., et al. Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the Cancer Pain Outcome Research Study Group. Clinical Journal of Pain 2011, 27(1):9-18.
12. Mercadante S. Managing breakthrough pain. Current Pain an Headache Reports 2011, 15(4):244-249.
13. Mercadante S., Radbruch L., Caraceni A., Cherny N., Kaasa S., Nauck F., et al. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 2002, 94(3):832-839.
14. Molassiotis A., Wengstrom Y., Kearney N. Symptom cluster patterns during the first year after diagnosis with cancer. Journal of Pain and Symptom Manage 2010, 39(5):847-858.
15. Paice J.A. Mechanisms and management of neuropathic pain in cancer. The Journal of Supportive Oncology 2003, 1(2):107-120.
16. Portenoy R., Forbes K., Lussier D., Hanks G. Difficult Pain Problems: An Integrated Approach 2004, Oxford Textbook of Palliative Medicine, Oxford.
17. Portenoy R.K. Treatment of temporal variations in chronic cancer pain. Seminars in Oncology 1997, 24(5 Suppl 16). S16-17-12.
18. Portenoy R.K. Treatment of cancer pain. The Lancet 2011, 377(9784):2236-2247.
19. Portenoy R.K., Hagen N.A. Breakthrough pain: definition, prevalence and characteristics. Pain 1990, 41(3):273-281.
20. Portenoy R.K., Payne D., Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999, 81(1-2):129-134.
21. Rostøen T., Wengström Y., Pappa D., Rundström C., Williams S.C. How nurses assess, advise about, and estimate the impact of breakthrough cancer pain in cancer patients. European Journal of Cancer Care 2013, 10.1111/ecc.12118.
22. Vadalouca A., Raptis E., Moka E., Zis P., Sykioti P., Siafaka I. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature. Pain Practice 2012, 12(3):219-251.
23. Zeppetella G. Impact and management of breakthrough pain in cancer. Current Opinions in Supportive Palliative Care 2009, 3(1):1-6.
24. Zeppetella G. Breakthrough pain in cancer patients. Clinical Oncology 2011, 23(6):393-398.
25. Zeppetella G., Ribeiro M.D. Pharmacotherapy of cancer-related episodic pain. Expert Opinions in Pharmacotherapy 2003, 4(4):493-502.